A core needle biopsy of the breast mass showed low-grade, estrogen receptor/ progesterone receptor (ER/PR)-positive, human epidermal growth factor receptor 2 (HER2)-negative invasive lobular carcinoma (Figure 2). The gene discussed is ERBB2; the disease is invasive lobular breast carcinoma.